US-based Iroko Pharmaceuticals has entered into a $75m debt facility agreement with an affiliate of OrbiMed Advisors (OrbiMed) to support general business operations and the launch of Zorvolex (diclofenac). Zorvolex is the first and only ...
US-based iCeutica announced that its partner Iroko Pharmaceuticals has received the US Food and Drug Administration (FDA) approval to market ZORVOLEX (diclofenac) capsules, a non-steroidal anti-inflammatory drug (NSAID) that utilizes ...
Sigma-Aldrich® Corporation announced its Supelco® brand launched the Ascentis® Express C18, 5 micron particle size column to improve speed and increase efficiencies in HPLC procedures. The new columns are based on innovative ...
Tags: Sigma-Aldrich, traditional HPLC systems, UHPLC, particle technology
DuPont, an American chemical company, plans to expand its $50m knowledge center in Hyderabad, India. The company has planned for the expansion in order to develop products and services in various fields for the global market. Following ...
Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class research into business, is pleased to announce that Seren Photonics Ltd (“Seren”), its LED technology company, has won a grant from the ...
Tags: Market View, led
Fusion IP plc (AIM: FIP), the university IP commercialisation company that turns world class research into business, is pleased to announce that Seren Photonics Ltd (“Seren”), its LED technology company, has won a grant from the ...
Tags: led
Seren Photonics Ltd,the LED technology portfolio company from UK-based university IP commercialization company Fusion IP plc,has won a 230,000 euros grant from the Technology Strategy Board(TSB),the UK government's national innovation ...
25 May 2012 Seren wins $230k UK R&D grant to speed commercialization of LED technology UK-based university IP commercialization company Fusion IP plc says that its LED technology portfolio company Seren Photonics Ltd (which was spun off ...
Tags: LEDs WhiteLEDs, Lights, Lighting, TSB gran